News & Updates
Filter by Specialty:
Chemo-induced nausea, vomiting? There’s a dexamethasone-free regimen for that
A dexamethasone-free regimen helps improve control of nausea and vomiting in patients receiving “highly emetogenic” chemotherapy, with the antiemetic effect being superior to that of a dexamethasone-based regimen, according to the results of a phase III trial presented at ASCO Breakthrough 2023.
Chemo-induced nausea, vomiting? There’s a dexamethasone-free regimen for that
28 Aug 2023
SNA a feasible HIV testing approach
Social network testing approaches (SNA) for HIV testing may be an effective and acceptable approach to improve HIV testing in all populations, a systematic review and meta-analysis suggests.
SNA a feasible HIV testing approach
28 Aug 2023
Functional anorectal pain ups incidence of ED, depression, anxiety in men
Men with functional anorectal pain (FARP) are more vulnerable to erectile dysfunction (ED), depression, and anxiety, a study has shown. Moreover, the incidence of these conditions increases with pain severity.
Functional anorectal pain ups incidence of ED, depression, anxiety in men
27 Aug 2023
QoL preserved in patients with refractory mCRC treated with add-on bevacizumab
In the treatment of refractory metastatic colorectal cancer (mCRC), the addition of bevacizumab to trifluridine/tipiracil (FTD/TPI) does not appear to hurt the quality of life (QoL), with patients receiving add-on bevacizumab being able to maintain their QoL for a longer period than those receiving FTD/TPI monotherapy, according to a post hoc analysis of the phase III SUNLIGHT trial.
